Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing a Sero-correlate of Protection Against Invasive Group B Streptococcus Disease in Newborns and Young Infants Aged <=90 Days

NCT02215226 is registered in ClinicalTrials.gov with University of Witwatersrand, South Africa as lead sponsor.

NCT NCT02215226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02215226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing a Sero-correlate of Protection Against Invasive Group B Streptococcus Disease in Newborns and Young Infants Aged <=90 Days
Lead sponsor
University of Witwatersrand, South Africa
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
December 31, 2016
Enrollment
35,274 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invasive group b streptococcus disease